The FDA Center for Drug Evaluation and Research has accepted a letter of intent for the first biomarker for idiopathic pulmonary fibrosis into its Biomarker Qualification Program, according to a press ...
Human Continuum Appoints Dr. Omar Khalid Sial, Ph.D., as its Chief Scientific Officer to Spearhead the Development of ...
Cartilage is the body’s most stubborn tissue. Once it wears away, it’s usually gone for good. This biological dead-end is the ...
Multiple Independent Molecular Signals Converge to Validate GRI-0621 as a Potential Disease-Modifying Therapy LA JOLLA, CA, Jan. 28, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or ...
Stocktwits on MSN
GRI Bio reports positive study results for chronic lung disease, but stock slumps 20% — what happened?
The latest findings include RNA-sequencing data showing that GRI-0621 significantly modulated genes associated with lung ...
Osteocytes, the most abundant cells in bone tissue, have long been underestimated in their functional capacity. Traditionally viewed as passive entities, recent research has illuminated their pivotal ...
This review innovatively proposes the use of electrospinning to fabricate electroactive fibrous scaffolds, which mimic the structure of the extracellular matrix while providing electrical activity, ...
Bone and skeletal injuries cause extensive and long-term functional impairments worldwide. In a new study, researchers at Lund University in Sweden show how a cell-free cartilage structure can safely ...
A team at Johns Hopkins Medicine has focused their work on myelin development using oligodendrocytes to help study conditions like MS.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results